Work

A phase Ib study of telatinib (BAY 57–9352), a VEGFR-2 inhibitor, in combination with docetaxel in patients with advanced solid tumours

Year: 2007

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.25.18_suppl.14035

Authors: H. M. Shaw, L. R. Molife, J. Spicer, V. Karavasilis, C. Marriott, T. J. Ong, L. Tate, E. Brendel, O. Christensen, J. S. de Bono

Institution: Royal Marsden Hospital

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1926779241

Cites:

Cited by:

Related to: 10